HCC: Updates from ILCA and ESMO 2022

December 06, 2023 00:30:22
HCC: Updates from ILCA and ESMO 2022
COR2ED - Oncology Medical Conversation
HCC: Updates from ILCA and ESMO 2022

Dec 06 2023 | 00:30:22

/

Show Notes

In this HCC CONNECT podcast HCC Experts Prof. Matthias Pinter and Prof. Jeroen Dekervel, discuss and debate the clinical implications of new HCC Phase 3 clinical trials data presented and discussed at the ILCA and ESMO congresses. They discuss Immuno-oncology agents and their place in the upcoming updated guidance such as the proposed new ILCA Systemic Therapies Guidance algorithm. They also discuss new treatment options in first line for advanced HCC presented at ESMO including the three late breaking abstracts LEAP-002, RATIONALE-301 and tislelizumab monotherapy trials. The latter two studying first-line treatment with an anti-PD1 antibody with or without a kinase inhibitor in patients with advanced hepatocellular carcinoma. The experts evaluate and provide their insights into how to integrate these new treatments for HCC in the clinical practice.

Other Episodes

Episode

January 10, 2024 00:31:12
Episode Cover

Treatment optimization in mCRC: third-line and beyond

Treatment of advanced colorectal cancer should be considered a continuum of care and patients should be offered as many life prolonging therapies as possible. ...

Listen

Episode

December 06, 2023 00:22:00
Episode Cover

GI cancer: Management of skin toxicity from multikinase inhibitors

In this podcast, Beth Wittmer RN, Director of Care Management at Florida Cancer Specialists, USA and Prof. Hans Prenen, GI Medical Oncologist from Antwerp...

Listen

Episode

December 06, 2023 00:21:28
Episode Cover

Precision oncology: Detection and treatment of TRK fusion-positive lung cancers

In this medical education podcast, NTRK CONNECT members Assoc. Prof. Caterina Marchiò (University of Turin, Italy) and Prof. Christian Rolfo (Center of Thoracic Oncology...

Listen